Pharmacy

Your Article Summary

See Latest Articles

Positive Phase II Results for GSK1838262 Reported for Subjects with Post-Herpetic Neuralgia and a History of Inadequate Response to Gabapentin
XenoPort, 10/06/09

GlaxoSmithKline and XenoPort, Inc. announced top–line results from a Phase II clinical trial evaluating GSK1838262/XP13512 in adult patients with neuropathic pain associated with post–herpetic neuralgia who have had a history of inadequate response to gabapentin doses of 1800 mg/day or higher.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimers disease: a post hoc analysis
Current Medical Research and Opinion, 11/25/09

Bayesian Modelling of Healthcare Resource Use in Multinational Randomized Clinical Trials
PharmacoEconomics, 11/24/09

Pandemic 2009 Influenza Update: Pandemrix data in children and adolescents from 3 to 17 years of age
GlaxoSmithKline, 11/24/09

 See all of Drug Trials

Today in Neuro/Psych pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Propylene Glycol Accumulation in Critically Ill Patients Receiving Continuous Intravenous Lorazepam Infusions
Annals of Pharmacotherapy, 11/25/09

Effect of cilnidipine vs losartan on cerebral blood flow in hypertensive patients with a history of ischemic stroke: a randomized controlled trial
Acta Neurologica Scandinavica, 11/25/09

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimers disease: a post hoc analysis
Current Medical Research and Opinion, 11/25/09

 See all of Neuro/Psych pharmacology